tiprankstipranks
Advertisement
Advertisement

APVO Stock Latest News

Aptevo Therapeutics Raises Capital Through Warrant-Induced Financing
Company AnnouncementsAptevo Therapeutics Raises Capital Through Warrant-Induced Financing
2d ago
8K
APVO
Aptevo Therapeutics Unveils New Solid Tumor Strategy
PremiumCompany Announcements
Aptevo Therapeutics Unveils New Solid Tumor Strategy
19d ago
8K
APVO
Aptevo files patent application for Nectin-4 x PD-L1 dual-targeting backbone
PremiumThe Fly
Aptevo files patent application for Nectin-4 x PD-L1 dual-targeting backbone
20d ago
APVO
Aptevo Therapeutics Secures Grant for APVO451 Development
PremiumCompany Announcements
Aptevo Therapeutics Secures Grant for APVO451 Development
2M ago
8K
APVO
Aptevo Therapeutics awarded $1.5M research grant from Andy Hill CARE Fund
PremiumThe Fly
Aptevo Therapeutics awarded $1.5M research grant from Andy Hill CARE Fund
2M ago
APVO
Aptevo Therapeutics appoints Janatpour as SVP, CSO
PremiumThe FlyAptevo Therapeutics appoints Janatpour as SVP, CSO
3M ago
APVO
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
Premium
Company Announcements
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
3M ago
8K
APVO
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
Premium
The Fly
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
3M ago
APVO
Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
PremiumThe Fly
Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
3M ago
APVO
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
PremiumThe Fly
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
3M ago
APVO
Aptevo Highlights Strong Phase 1b AML Trial Results
PremiumCompany Announcements
Aptevo Highlights Strong Phase 1b AML Trial Results
3M ago
8K
APVO
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
PremiumThe Fly
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
5M ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
PremiumThe FlyAptevo Therapeutics sees cash runway into 4Q26
5M ago
APVO
Aptevo Reports Promising Interim Data for AML Therapy
Premium
Company Announcements
Aptevo Reports Promising Interim Data for AML Therapy
5M ago
8K
APVO
Aptevo Therapeutics announces interim data for mipletamig combination
Premium
The Fly
Aptevo Therapeutics announces interim data for mipletamig combination
5M ago
APVO
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
PremiumCompany Announcements
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
6M ago
8K
APVO
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
PremiumCompany Announcements
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
6M ago
8K
APVO
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
PremiumThe Fly
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
6M ago
APVO
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
PremiumThe Fly
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
7M ago
APVO
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
PremiumCompany AnnouncementsAptevo Therapeutics Secures $60 Million Equity Financing Facility
7M ago
8K
APVO
Aptevo Therapeutics secures $60M equity line of credit
Premium
The Fly
Aptevo Therapeutics secures $60M equity line of credit
7M ago
APVO
Aptevo Therapeutics trading halted, news pending
Premium
The Fly
Aptevo Therapeutics trading halted, news pending
8M ago
APVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >